https://www.avient.com/sites/default/files/2020-12/onflex-interior-tray-english.pdf
TIER 2 SUPPLIER I N T E R I O R T R A Y S • A low FOG material with low odor • Low gloss finish • Easy processability • Enabled easier processing than the incumbent TPE-v • Eliminated pre-drying step and delivered pre-colored material, improving process efficiencies • Met needs for low fogging (≤2 mg) and low odor (≤3.0) with low gloss finish OnFlex™ S EH 80A-3S7005 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-05/Safety goggles - Application snapshot.pdf
SAFETY PROTECTION BRAND S A F E T Y G O G G L E G A S K E T • Good adhesion onto polycarbonate (PC) • Flexible and comfortable to wear • FDA compliant • Customized a Shore 43A TPE with good adhesion to PC frame • Delivered soft-touch and non-tacky feel • Complied with FDA 21 CFR 177.2600 Custom Versaflex™ Thermoplastic Elastomers (TPEs) KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ WithStand_ Antimicrobial Additives-Medical Gown-Case study snapshot.pdf
Medical gown manufacturer MEDICAL GOWN MANUFACTURER P P N O N W O V E N M U L T I L A Y E R S • Excellent anti-microbial and anti-virus performance • Pass JIS Test • Provide technical support including specific specs, processing and molding recommendations • Customized anti-virus solutions designed to support performance standards for materials used in the surgical environment • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Supported customer’s products pass the JIS test Cesa WithStand Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ Fiber Additives-fabric mask-case study snapshot.pdf
FABRIC MASK MANUFACTURER P P N O N W O V E N M U L T I L A Y E R S • Meet regulatory requirements for the application • Provide technical support including specific color, processing and molding recommendations • Deliver a highly hydrophilic performance • Developed a compliant additives solution to meet necessary regulatory specifications • Provided technical expertise throughout the design and manufacturing process • Offered an effective solution to make it soft touch while hydrophilic Cesa Fiber Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ Slip Additives-baby diaper -Case Study Snapshot-CNSHA3OLH90098.pdf
Baby diaper manufactureR BABY DIAPER MANUFACTURER P P N O N W O V E N M U L T I L A Y E R S • Provide slip additives with high concentrated content • Offer products meeting customer FDA requirements • Shorten supply lead time and reduce cost compared with importing from EU • Offered additives with high concentrated content, which is unachievable for competitors • Provided regulatory support, significant cost and time savings • Compressed the timeline through on-site color visualization, exploration, and formulation of new colors by the expert designer Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Italian.pdf
Quale azienda facente parte del programma Responsible Care® dell’American Chemistry Council (Consiglio di chimica americano) e membro fondatore dell’Alliance to End Plastic Waste (Alleanza per porre fine ai rifiuti in plastica), ci impegniamo anche attraverso il nostro punto di riferimento, No Surprises PledgeSM (impegno a non riservare sorprese) e la nostra Promessa di sostenibilità.
Quale azienda facente parte del programma Responsible Care® dell’American Chemistry Council (Consiglio di chimica americano) e membro fondatore dell’Alliance to End Plastic Waste (Alleanza per porre fine ai rifiuti in plastica), ci impegniamo anche attraverso il nostro punto di riferimento, No Surprises PledgeSM (impegno a non riservare sorprese) e la nostra Promessa di sostenibilità, e sosteniamo questi principi vivendo secondo i valori personali di integrità, onestà e rispetto.
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Portuguese.pdf
Como uma empresa Responsible Care® do Conselho Americano de Química (American Chemistry Council) e membro fundador da Aliança para o Fim dos Resíduos Plásticos (Alliance to End Plastic Waste), estamos ainda mais comprometidos com o nosso lema No Surprises PledgeSM (Não haverá surpresas) e com a nossa Promessa de Sustentabilidade.
Como uma empresa Responsible Care® do Conselho Americano de Química (American Chemistry Council) e membro fundador da Aliança para o Fim dos Resíduos Plásticos (Alliance to End Plastic Waste), estamos ainda mais comprometidos por meio do nosso lema No Surprises PledgeSM (Não haverá surpresas) e da nossa promessa de sustentabilidade; além disso, defendemos esses princípios vivendo os valores pessoais de integridade, honestidade e respeito.
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of October 25, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of October 25, 2021 86 92 85 82 79 77 74 89 83 82 80 79 79 78 78 72 33 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E H X L B N R A S H E C L E M N H U N S C L A L B (12) Source: Peer data per Bloomberg market data as of October 25, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.
With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.0 18.3 16.3 15.4 14.5 11.6 11.1 36.2 28.0 24.9 13.0 11.5 11.3 10.0 9.2 8.8 7.7 6.7 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2023-05/AVNT Q1 2023 Earnings Presentation.pdf
GUIDANCE (TOTAL COMPANY) 7 14.8% 15.8% Guidance Actual Adjusted EBITDA Margin % Better-than-expected margins driven by: • Resilient demand for composites and sustainable solutions which improved mix of higher margin applications • Deceleration of raw material inflation • Cost reduction activities Q1 EBITDA BRIDGE (TOTAL COMPANY) 8 $ millions CAI: Price / Mix 19) Inflation (4) SEM: Price / Mix 6) Inflation (4) Net Price Benefit 17) Wage and Energy Inflation (13) Cost Reductions 8) FX (6) Q1 2023 Actual $134) Adjusted EBITDA Q1 2022 Pro Forma $ 176) Demand (48) • Weak demand conditions in-line with previous expectations • Pricing continues to cover inflation of raw materials, wages and energy U.S. & Canada 40% EMEA 38% Asia 17% Latin America 5% Q1 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 18% Packaging 23% Healthcare 7% Industrial 16% Building and Construction 10% Defense 6%Telecommunications 4% Energy 5% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $846M and $134M, respectively, include intercompany sales eliminations and corporate costs $537M $91M $310M $64M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $134M$846M (1) 9 Transportation 11% Q1 2023 SALES BY REGION Yo Y C H A N G E ( E X C L .
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 32 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi en t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 33 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_VIT2.pdf
Chúng ta cũng phải chấp nhận ý kiến từ những người khác theo cách tương tự.
Đảm bảo an toàn cho mọi người đòi hỏi phải có ý thức liên tục và chú ý đến chi tiết.
Xác nhận Tuân thủ: Tôi đã đọc, hiểu và đồng ý tuân thủ Bộ Quy tắc Ứng xử của Avient.